BCR and inflammation: Further, high pelvic inflammation (HR: 1.32; 95% CI, 1.03–1.68; p = 0.0274), pT3 stage (HR: 3.36 95% CI, 2.62–4.30; p = < 0.0001) and PSA (HR: 2.81; 95% CI, 2.81–3.60; p ≤ 0.0001) were also significantly associated with time to BCR (Supplementary Table S6).